Search Results 2041-2050 of 15511 for Epilepsy (Partial Onset)

  1. LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer - Mayo Clinic

    ... partial mastectomy for DCIS (whether or not undergoing planned SLNB) or Stage I-II primary invasive breast cancer undergoing SLNB. Safety is the primary ...

  2. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

    measures for the duration of the study and be willing and able to continue ... partial thromboplastin time (aPTT) ≥1.5 × ULN, or serum albumin ≤3 gm/dL ...

  3. RA-PRO PRAGMATIC TRIAL - Mayo Clinic

    ... duration prior to the first dose of study drug; AND; Glucocorticoid and NSAID treatment - If receiving glucocorticoids (≤ 10 mg/day of prednisone of ...

  4. PF-04449913 Single-Agent In Patients with Myelofibrosis Previously Treated with a Janus Kinase Inhibitor - Mayo Clinic

    Previous treatment with 1 or more JAK inhibitors (licensed or experimental) for a minimum duration of at least 4 weeks and failure to achieve or sustain ...

  5. Computer Vision-based Assessment of Upper Extremity Motor Function in Stroke Patients - Mayo Clinic

    History of seizures; History of musculoskeletal impairment affecting upper extremity strength or range of motion; History of CNS malignancy. Participating Mayo ...

  6. A Study to Evaluate CPI-006 with Standard of Care vs. Placebo with Standard of Care in Mild-to-moderately Symptomatic Hospitalized Covid-19 Patients (Enrolling by Invitation Only) - Mayo Clinic

    Covid-19 illness of any duration of symptoms. ... Participant must understand and agree to comply with planned study procedures for the duration of the study.

  7. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

    Patients are not permitted to receive enzyme inducing anti-epileptic drugs. Patients who have developed brain metastases during Part I of the study may ...

  8. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

    About this study. The purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of ...

  9. Neurology Patient Stories - 2020 Archives - Mayo Clinic News Network

    Fresh Approach to Epilepsy Treatment Rekindles Zest for Life. Joel Streed ... With Her Seizures in the Past, Keeley Faces a Promising Future featured image.

  10. Publications - Abigail L. Matthews, Ph.D., M.H.A., L.P., ABPP - Mayo Clinic

    ... onset adolescent eating disorders. Appetite. 2016 Oct 1; 105:298-305 Epub 2016 June 02. View PubMed; Matthews A, Peterson CM. Intensive family-based therapy ...